Personalized Deintensification Therapy For HPV-Positive Head And Neck Cancers
About this episode
This episode features a discussion on personalized deintensification therapy for HPV-positive head and neck cancers, focusing on its benefits and nuances.
Head and neck reconstructive surgeon Karthik Rajasekaran, MD, and radiation oncologist Michelle Gentile, MD, discuss the nuances and benefits of deintensification, a personalized approach to care for individuals with HPV-positive head and neck cancers that aims to maintain high cure rates while reducing long-term toxicities. (Part 1 of 2)
More episodes of Penn Medicine Physician Interviews
- Studies in Radiation-Oncology: Deintensification Therapy for HPV+ Head and Neck Cancers
- Genomic Determinants and Biomarkers: Defining Leukemias
- Low-Dose Radiation Therapy Emerges as a Viable Alternative for Refractory Osteoarthritis
Explore listener stats, chart rankings, contacts and more on the Penn Medicine Physician Interviews podcast page.